Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Perreault · SciRah

Researcher profile · Semantic Scholar

S. Perreault

Share profile

S. Perreault — researcher profile on SciRah

h-index: 31
Works: 189
Citations: 3,703

Most-cited papers

The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial
L. Kilburn, Dong-Anh Khuong-Quang, J. Hansford, Daniel B. Landi +38 more
2023Nature Medicine169 citations Open access
Semantic Scholar
K27M in canonical and noncanonical H3 variants occurs in distinct oligodendroglial cell lineages in brain midline gliomas
Selin Jessa, Abdulshakour Mohammadnia, A. Harutyunyan, Maud Hulswit +30 more
2022Nature Genetics93 citations Open access
Semantic Scholar
MRI Radiogenomics of Pediatric Medulloblastoma: A Multicenter Study.
Michael Zhang, Samuel W Wong, J. Wright, M. Wagner +35 more
2022Radiology71 citations Open access
Semantic Scholar
An international study presenting a federated learning AI platform for pediatric brain tumors
Edward H. Lee, M. Han, Jason N. Wright, Michael S. Kuwabara +40 more
2024Nature Communications58 citations Open access
Semantic Scholar
Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study.
A. Ercan, M. Aronson, Nick Fernandez, Yuan Chang +124 more
2024The Lancet Oncology58 citations Open access
Semantic Scholar
LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration
C. van Tilburg, L. Kilburn, S. Perreault, René Schmidt +22 more
2024BMC Cancer52 citations Open access
Semantic Scholar
Extent of Tumor Resection and Survival in Pediatric Patients With High-Grade Gliomas
Rami Hatoum, Jia-Shu Chen, P. Lavergne, N. Shlobin +12 more
2022JAMA Network Open47 citations Open access
Semantic Scholar
Systematic review of diffuse hemispheric glioma, H3 G34-mutant: Outcomes and associated clinical factors
C. Crowell, D. Mata-Mbemba, J. Bennett, K. Matheson +3 more
2022Neuro-Oncology Advances43 citations Open access
Semantic Scholar
Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti–PD-1 Monotherapy: A Report from the International RRD Consortium
Anirban Das, Nick Fernandez, A. Levine, V. Bianchi +59 more
2023Cancer Discovery41 citations Open access
Semantic Scholar
LOGGIC/FIREFLY-2: A phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration.
C. van Tilburg, L. Kilburn, Erin E. Crotty, Amy A. Smith +16 more
2023Journal of Clinical Oncology35 citations
Semantic Scholar
Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation–Sparing Approaches: An International Cohort Study
C. Erker, M. Mynarek, S. Bailey, C. Mazewski +54 more
2022Journal of Clinical Oncology26 citations Open access
Semantic Scholar
Treatment of Refractory Epilepsy With MEK Inhibitor in Patients With RASopathy.
G. D'Onofrio, M. Delrue, A. Lortie, Christopher Marquis +4 more
2023Pediatric Neurology20 citations
Semantic Scholar
Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors
Leo Mascarenhas, S. Dubois, Catherine M. Albert, S. Bielack +20 more
2025Journal of Clinical Oncology17 citations Open access
Semantic Scholar
Upfront BRAF/MEK inhibitors for treatment of high-grade glioma: A case report and review of the literature
Gabrielle Arbour, B. Ellezam, A. Weil, R. Cayrol +6 more
2022Neuro-Oncology Advances15 citations Open access
Semantic Scholar
Canadian Consensus for Treatment of BRAF V600E Mutated Pediatric and AYA Gliomas
C. Erker, M. Vanan, V. Larouche, L. Nobre +24 more
2024Current Oncology13 citations Open access
Semantic Scholar
Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trial
K. Nysom, L. Kilburn, Sarah E. S. Leary, Daniel B. Landi +25 more
2024Neuro-Oncology12 citations Open access
Semantic Scholar
MDB-92. EFFECT OF REDUCED-DOSE CRANIOSPINAL IRRADIATION AND REDUCED-DOSE ADJUVANT CHEMOTHERAPY ON CHILDREN AND ADOLESCENTS WITH WNT MEDULLOBLASTOMA WITHOUT RESIDUAL OR METASTATIC DISEASE: RESULTS FROM THE SJMB12 CLINICAL TRIAL
G. Robinson, T. Merchant, Brent A. Orr, J. Bass +41 more
2024Neuro-Oncology11 citations Open access
Semantic Scholar
Selumetinib for symptomatic, inoperable plexiform neurofibromas in children with neurofibromatosis type 1: A national real‐world case series
Hallie Coltin, S. Perreault, V. Larouche, K. Black +7 more
2022Pediatric Blood & Cancer11 citations
Semantic Scholar
Germline analysis of an international cohort of pediatric diffuse midline glioma patients
M. Mateos, P. Ajuyah, N. Fuentes-Bolanos, Sam El-Kamand +34 more
2025Neuro-Oncology10 citations Open access
Semantic Scholar
LGG-09. CLINICAL ACTIVITY OF PAN-RAF INHIBITOR TOVORAFENIB IN THE REGISTRATIONAL PEDIATRIC LOW-GRADE GLIOMA ARM OF THE PHASE 2 FIREFLY-1 (PNOC026) STUDY
L. Kilburn, Dong-Anh Khuong-Quang, K. Nysom, D. Landi +16 more
2023Neuro-Oncology10 citations Open access
Semantic Scholar
Impact of trametinib on the neuropsychological profile of NF1 patients
E. Lalancette, Édith Cantin, Marie-Éve Routhier, C. Mailloux +25 more
2024Journal of Neuro-Oncology9 citations
Semantic Scholar
Salvage therapies for first relapse of SHH medulloblastoma in early childhood
C. Erker, M. Mynarek, M. Simbozel, Brandon T. Craig +47 more
2025Neuro-Oncology7 citations Open access
Semantic Scholar
Quality-of-Life Assessment in Pediatric Advanced Cancer: Development of the Patient-Reported Outcome Measure Advance QoL
Lye-Ann Robichaud, J. Felipe, Michel Duval, Bruno Michon +5 more
2024Current Oncology6 citations Open access
Semantic Scholar
Epidemiology of Pediatric Tumors in Quebec: A 17-Year Report of Cancer in Young People in the Canada Registry
Caroline Bellavance, B. Lalonde, D. Simonyan, N. Jabado +2 more
2024Current Oncology5 citations Open access
Semantic Scholar
Time-frequency analyses of repetition suppression and change detection in children with neurofibromatosis type 1.
E. Lalancette, Audrey-Rose Charlebois-Poirier, K. Agbogba, Inga Sophia Knoth +3 more
2023Brain Research5 citations
Semantic Scholar
Intermittent neurologic decompensation: An underrecognized presentation of tyrosine hydroxylase deficiency
Marjolaine Champagne, G. Horvath, S. Perreault, J. Gauthier +3 more
2022JIMD Reports5 citations Open access
Semantic Scholar
Targeted Transition Readiness Workshops for Pediatric Brain Tumor Survivors: Feasibility, Acceptability, and Preliminary Effects
Julie Carrier, Tziona Lugasi, Nathalie Labonté, Carole Provost +9 more
2025Current Oncology4 citations Open access
Semantic Scholar
HGG-02. LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TRK FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS: AN UPDATED ANALYSIS
S. Perreault, F. Doz, R. Deyell, R. Kebudi +9 more
2024Neuro-Oncology4 citations Open access
Semantic Scholar
Development of a semi-automatic segmentation technique based on mean magnetic resonance imaging intensity thresholding for volumetric quantification of plexiform neurofibromas
D. S. Kiaei, Ramy El Jalbout, J. Décarie, S. Perreault +1 more
2023Heliyon4 citations Open access
Semantic Scholar
Cerebrospinal Fluid Liquid Biopsy Enables Targeted Therapy Without Tissue Diagnosis in Pediatric Low‐Grade Gliomas With BRAF V600E Mutation
H. Sultan, D. Faury, Alexander G. Weil, H. Westwick +2 more
2026Pediatric Blood & Cancer3 citations Open access
Semantic Scholar
TRAM-01: A phase 2 study of trametinib for pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas
Dorsa Sadat Kiaei, M. Caru, V. Larouche, E. Clini +31 more
2026Neuro-Oncology3 citations Open access
Semantic Scholar
A National Modified Delphi Consensus on the Referral and Management of NF1 Plexiform Neurofibroma
L. Lafay-Cousin, S. Perreault, Dal Singh, Katie Larner +1 more
2025Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques3 citations Open access
Semantic Scholar
Advances in pediatric gliomas: from molecular characterization to personalized treatments
Sayanthen Sathyakumar, Matthew Martinez, S. Perreault, G. Legault +4 more
2024European Journal of Pediatrics3 citations
Semantic Scholar
EPID-10. CNSONTRK STUDY: CLINICAL CHARACTERISTICS AND OUTCOME OF CENTRAL NERVOUS SYSTEM TUMORS HARBORING NTRK GENE FUSIONS
Audrey-Anne Lamoureux, Michael Fisher, L. Lemelle, E. Pfaff +46 more
2023Neuro-Oncology3 citations Open access
Semantic Scholar
High-resolution proteomic analysis of medulloblastoma clinical samples identifies therapy resistant subgroups and MYC immunohistochemistry as a powerful outcome predictor.
A. Delaidelli, F. Burwag, S. Ben-Neriah, Yujin Suk +17 more
2025Neuro-Oncology2 citations
Semantic Scholar
LGG-40. TYPE II RAF INHIBITOR TOVORAFENIB IN RELAPSED/REFRACTORY PEDIATRIC LOW-GRADE GLIOMA (PLGG): REVERSIBLE DECREASES IN GROWTH VELOCITY IN THE PHASE 2 FIREFLY-1 TRIAL
C. Kline, A. Waanders, D. Ziegler, L. Kilburn +38 more
2024Neuro-Oncology2 citations Open access
Semantic Scholar
HGG-39. CLINICAL CHARACTERISTICS AND SURVIVAL OUTCOMES OF DIFFUSE HEMISPHERIC GLIOMA, H3 G34-MUTANT: INTERIM RESULTS OF A MULTICENTRE INTERNATIONAL STUDY
C. Crowell, J. Bennett, P. Bandopadhayay, D. Sturm +29 more
2024Neuro-Oncology2 citations Open access
Semantic Scholar
Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial
L. Kilburn, Dong-Anh Khuong-Quang, J. Hansford, Daniel B. Landi +38 more
2024Nature Medicine2 citations Open access
Semantic Scholar
CTNI-07. LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TRK FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS: AN UPDATED ANALYSIS
S. Perreault, Jean-Philippine Spano, Anna B. Nilsson, R. Deyell +13 more
2024Neuro-Oncology2 citations
Semantic Scholar
CTNI-24. CLINICAL ACTIVITY AND SAFETY OF THE RAF INHIBITOR TOVORAFENIB IN PATIENTS WITH OPTIC PATHWAY GLIOMAS IN THE REGISTRATIONAL PEDIATRIC LOW-GRADE GLIOMA ARM OF THE PHASE 2 FIREFLY-1 (PNOC026) STUDY
K. Nysom, L. Kilburn, Sarah E. S. Leary, Daniel B. Landi +26 more
2023Neuro-Oncology2 citations Open access
Semantic Scholar
ID #515 TRAM-01: A Phase 2 study of trametinib for patients with pediatric low grade glioma with activation of the MAPK/ERK pathway.
S. Perreault, V. Larouche, Nour Eltaani, U. Tabori +22 more
2026Neuro-Oncology Pediatrics1 citations Open access
Semantic Scholar
ID #832 FIREFLY-1 3-Year Results: Impact of Prior Therapy on Tovorafenib Activity in BRAF-Altered Pediatric Low-Grade Glioma
Dong-Anh Khuong-Quang, Daniel B. Landi, Cassie Kline, Darren R. Hargrave +13 more
2026Neuro-Oncology Pediatrics1 citations Open access
Semantic Scholar
Advances in the management of pediatric low-grade glioma
M. Brizini, S. Perreault, J. Bennett, H. Hassan
2026Neurotherapeutics1 citations Open access
Semantic Scholar
ID #276 Long-term medical and psychosocial outcomes of a population-based, molecularly characterized pediatric low-grade glioma survivor cohort
Z. Ante, A. Babujee, Ning Liu, J. Mcmahon +15 more
2026Neuro-Oncology Pediatrics1 citations Open access
Semantic Scholar
CTP-17. Clinical stability following tovorafenib treatment in relapsed/refractory pediatric low-grade glioma: updated results from the phase 2 FIREFLY-1 trial
C. Kline, D. Hargrave, Dong-Anh Khong-Quang, Daniel B. Landi +12 more
2025Neuro-Oncology1 citations
Semantic Scholar
Long-term Efficacy and Safety of Larotrectinib in Pediatric Patients with Primary CNS and Non-Primary CNS TRK Fusion Tumors
Omar Chamdine, L. Mascarenhas, F. Doz, B. Geoerger +14 more
2025OncoDaily Medical Journal1 citations
Semantic Scholar
Bevacizumab in Pediatric Neuro-Oncology
Jacob Silverman, Sayanthen Sathyakumar, H. Coltin, S. Perreault +3 more
2025Current Oncology1 citations Open access
Semantic Scholar
Sustained response to trametinib in an adult patient with neurofibromatosis type 1 and high-grade glioma
Bertrand Dion, Sayanthen Sathyakumar, Jacob Silverman, H. Coltin +10 more
2025Child's Nervous System1 citations
Semantic Scholar
LGG-49. EVALUATING THE EFFECTS OF MIRDAMETINIB IN NF1-MUTANT LOW-GRADE GLIOMAS USING BOTH CULTURED CELLS AND A NOVEL ZEBRAFISH XENOGRAFT MODEL
Inci Yaman Bajin, R. Siddaway, Adrian Levine, T. McKeown +19 more
2024Neuro-Oncology1 citations Open access
Semantic Scholar
CTNI-09. TYPE II RAF INHIBITOR TOVORAFENIB IN RELAPSED/REFRACTORY (R/R) PEDIATRIC LOW-GRADE GLIOMA (PLGG): RESULTS FROM PATIENTS ON A DRUG HOLIDAY (DH) IN THE PHASE 2 FIREFLY-1 TRIAL
S. Perreault, Dong-Anh Khuong-Quang, L. Kilburn, Daniel B. Landi +35 more
2024Neuro-Oncology1 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

V. Larouche×18
Invite
V. Larouche — researcher profile on SciRah
J. Hansford×13
Invite
J. Hansford — researcher profile on SciRah
N. Jabado×13
Invite
N. Jabado — researcher profile on SciRah
K. Nysom×12
Invite
K. Nysom — researcher profile on SciRah

×11

Invite

L. Kilburn — researcher profile on SciRah

Invite

P. Manley — researcher profile on SciRah

Dong-Anh Khuong-Quang×10

Invite

Dong-Anh Khuong-Quang — researcher profile on SciRah

É. Bouffet×10

Invite

É. Bouffet — researcher profile on SciRah

Invite

C. Erker — researcher profile on SciRah

Invite

C. Kline — researcher profile on SciRah

Invite

N. Gottardo — researcher profile on SciRah

Invite

U. Tabori — researcher profile on SciRah